Government and private funding for genomic research is the key factor driving market revenue growth. According to the Alzheimer’s Disease International, As of June 2024, it is anticipated that more ...

Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bw8517 ...

PORTLAND, IL, UNITED STATES, March 11, 2025 /EINPresswire / -- The proteomics market is witnessing significant growth propelled by advancements in technology, such as mass spectrometry and protein ...

The global peptide microarray market share analysis is on a steady growth trajectory, projected to reach USD 903.8 million by 2025, with a compound annual growth rate (CAGR) of 3.8%. By 2035, the ...

Non-contact dispensing of droplets or "jetting" is the precise depositing of tiny liquid droplets, ranging from picoliters to ...

Clinical-stage biotechnology company Vaxxas has announced the publication of data supporting the potential use of its ...

Partnership to Deliver More Effective Treatments for Skin-Based and Immune-Mediated Applications Our BioForge collaboration is a key advan ...

New data announced by Vaxxas supports the use of its high-density microarray patch (HD-MAP) technology to deliver DNA-based ...

Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform, today announced the publication of data supporting the effective use of its high-density microarray patch ...

One of the primary obstacles in microarray-based cancer classification is the disproportionate number of features relative to patient samples, leading to model overfitting and reduced accuracy.

Mar. 6, 2025 — The enormous computing resources needed to train neural networks for artificial intelligence (AI) result in massive power consumption. Researchers have developed a method that is ...

The clinical study aims to evaluate a vaccine for avian influenza A (H7N9) delivered by Vaxxas’ high-density microarray patch ... with its HD-MAP vaccination technology, which delivers vaccines ...